Effectiveness of a combination therapy of traditional Chinese medicine and CO2 laser treatment for condyloma acuminatum

医学 尖锐湿疣 CD8型 内科学 中医药 细胞免疫 回廊的 人乳头瘤病毒 胃肠病学 外科 免疫学 免疫系统 病理 替代医学
作者
Huaxiang Xu,Qinglin Shen,Bing Fan,Changqing Xi,Lili Wang
出处
期刊:Journal of Medical Virology [Wiley]
卷期号:92 (12): 3889-3894 被引量:6
标识
DOI:10.1002/jmv.25923
摘要

Abstract Background Condyloma acuminatum (CA) is both highly infectious and frequently recurring and requires long‐term, repeated treatments, which seriously affect the physical and psychological health of patients. The purpose of the present study was to investigate the effectiveness of a combination therapy of traditional Chinese medicine and CO 2 laser on CA and the relationship between CA relapse and cellular immunity. Methods The study cohort consisted of 160 CA patients who underwent ambulatory treatment between January 2017 and January 2019 in the Department of Dermatology and Venerology of our hospital. The 160 patients were randomly divided into two groups: a combination therapy group (80 cases), who underwent CO 2 ‐laser treatment followed by three courses of oral traditional Chinese medicine and a control group (80 cases), who were only treated with the CO 2 laser to remove warts. The efficacy of the CO 2 ‐laser treatment was evaluated on the first month after treatment and relapse was evaluated at monthly follow‐ups for 6 months. Additionally, 20 normal volunteers were also recruited. Three months before and after treatment, the cellular immunity factors of peripheral blood T lymphocyte subsets, including CD4+, CD8+, CD4+/CD8+, and interleukin‐2 (IL‐2), were detected and compared between CA patients and normal volunteers, the combination therapy and control groups, and the relapse and cure groups to determine whether there were statistical differences. Results Compared with normal volunteers, CA patients exhibited lower CD4+, CD4+/CD8+, and IL‐2 levels and higher CD8+ levels ( P < .05). In addition, the rates of relapse for the combination therapy and control groups were 25.7% and 40.8%, respectively. However, the comprehensive immunity factors showed no statistical difference ( P > .05) before treatment. Three months after treatment, factors including CD4+ and CD4+/CD8+ were higher in the combination therapy group than in the control group ( P < .05), and CD8+ and IL‐2 showed no statistical difference ( P > .05); factors including CD4+, CD4+/CD8+, and IL‐2 were higher and CD8+ was lower in the cure group than in the relapse group ( P < .05). Conclusion The therapy combination of traditional Chinese medicine and CO 2 ‐laser treatment can reduce the relapse rate of CA. It might be that traditional Chinese medicine combined with CO2‐laser treatment regulate liver meridian, Qi and blood, and restore the balance between various subgroups.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
虚幻初之发布了新的文献求助10
刚刚
科研通AI6.1应助微微采纳,获得10
1秒前
Meng完成签到,获得积分10
1秒前
1秒前
科研通AI6.1应助子木采纳,获得10
1秒前
MARIO完成签到 ,获得积分10
2秒前
2秒前
小蘑菇应助科研通管家采纳,获得10
2秒前
2秒前
书晴完成签到 ,获得积分10
2秒前
Mark应助科研通管家采纳,获得10
2秒前
轨迹应助科研通管家采纳,获得20
2秒前
深情安青应助科研通管家采纳,获得10
2秒前
华仔应助科研通管家采纳,获得50
3秒前
搜集达人应助科研通管家采纳,获得10
3秒前
3秒前
脑洞疼应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
3秒前
李健应助科研通管家采纳,获得10
3秒前
清醒完成签到,获得积分20
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
4秒前
赘婿应助科研通管家采纳,获得10
4秒前
4秒前
我要发sci发布了新的文献求助10
4秒前
小蘑菇应助科研通管家采纳,获得10
4秒前
传奇3应助科研通管家采纳,获得10
4秒前
轨迹应助科研通管家采纳,获得20
4秒前
深情安青应助科研通管家采纳,获得10
4秒前
我是老大应助科研通管家采纳,获得10
4秒前
华仔应助科研通管家采纳,获得50
4秒前
4秒前
搜集达人应助科研通管家采纳,获得10
5秒前
Owen应助科研通管家采纳,获得10
5秒前
5秒前
脑洞疼应助科研通管家采纳,获得10
5秒前
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Quaternary Science Reference Third edition 6000
Encyclopedia of Forensic and Legal Medicine Third Edition 5000
Introduction to strong mixing conditions volume 1-3 5000
Aerospace Engineering Education During the First Century of Flight 3000
Agyptische Geschichte der 21.30. Dynastie 3000
Les Mantodea de guyane 2000
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5784847
求助须知:如何正确求助?哪些是违规求助? 5684004
关于积分的说明 15465575
捐赠科研通 4913804
什么是DOI,文献DOI怎么找? 2644941
邀请新用户注册赠送积分活动 1592845
关于科研通互助平台的介绍 1547234